177 related articles for article (PubMed ID: 11457995)
41. BVDV alters uterine prostaglandin production during pregnancy recognition in cows.
Cheng Z; Abudureyimu A; Oguejiofor CF; Ellis R; Barry AT; Chen X; Anstaett OL; Brownlie J; Wathes DC
Reproduction; 2016 Jun; 151(6):605-14. PubMed ID: 26952097
[TBL] [Abstract][Full Text] [Related]
42. Stability of Bovine viral diarrhea virus 1 nucleic acid in fetal bovine samples stored under different conditions.
Ridpath JF; Neill JD; Chiang YW; Waldbillig J
J Vet Diagn Invest; 2014 Jan; 26(1):6-9. PubMed ID: 24352225
[TBL] [Abstract][Full Text] [Related]
43. Influence of interferons alpha I1 and gamma and of tumour necrosis factor on persistent infection with bovine viral diarrhoea virus in vitro.
Bielefeldt Ohmann H; Babiuk LA
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1399-403. PubMed ID: 2838577
[TBL] [Abstract][Full Text] [Related]
44. Correlation of bovine viral diarrhoea virus induced cytopathic effects with expression of a biotype-specific marker.
Greiser-Wilke I; Liess B; Schepers J; Stahl-Hennig C; Moennig V
Arch Virol Suppl; 1991; 3():55-66. PubMed ID: 9210926
[TBL] [Abstract][Full Text] [Related]
45. Host response to bovine viral diarrhea virus and interactions with infectious agents in the feedlot and breeding herd.
Fulton RW
Biologicals; 2013 Jan; 41(1):31-8. PubMed ID: 22890128
[TBL] [Abstract][Full Text] [Related]
46. Experimental inoculation of pregnant swine with type 1 bovine viral diarrhoea virus.
Walz PH; Baker JC; Mullaney TP; Maes RK
J Vet Med B Infect Dis Vet Public Health; 2004 May; 51(4):191-3. PubMed ID: 15228555
[TBL] [Abstract][Full Text] [Related]
47. Antigenically different pestivirus strains induce congenital infection in sheep: a model for bovine virus diarrhea virus vaccine efficacy studies.
Bruschke CJ; van Rijn PA; Moormann RJ; van Oirschot JT
Vet Microbiol; 1996 May; 50(1-2):33-43. PubMed ID: 8810006
[TBL] [Abstract][Full Text] [Related]
48. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
[TBL] [Abstract][Full Text] [Related]
49. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
[TBL] [Abstract][Full Text] [Related]
50. A novel nested reverse transcription PCR detects bovine viral diarrhoea virus in fluids from aborted bovine fetuses.
Hyndman L; Vilcek S; Conner J; Nettleton PF
J Virol Methods; 1998 Mar; 71(1):69-76. PubMed ID: 9628223
[TBL] [Abstract][Full Text] [Related]
51. Effects of interferon-tau on cattle persistently infected with bovine viral diarrhea virus.
Kohara J; Nishikura Y; Konnai S; Tajima M; Onuma M
Jpn J Vet Res; 2012 Aug; 60(2-3):63-70. PubMed ID: 23094581
[TBL] [Abstract][Full Text] [Related]
52. Prolonged persistence of cytopathogenic bovine viral diarrhea virus (BVDV) in a persistently viremic cattle.
Moennig V; Greiser-Wilke I; Frey HR; Haas L; Liebler E; Pohlenz J; Liess B
Zentralbl Veterinarmed B; 1993 Jul; 40(5):371-7. PubMed ID: 8237210
[TBL] [Abstract][Full Text] [Related]
53. Cytopathic and non-cytopathic bovine viral diarrhoea virus biotypes affect fluid phase uptake and mannose receptor-mediated endocytosis in bovine monocytes.
Boyd BL; Lee TM; Kruger EF; Pinchuk LM
Vet Immunol Immunopathol; 2004 Nov; 102(1-2):53-65. PubMed ID: 15451615
[TBL] [Abstract][Full Text] [Related]
54. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
55. A congenital persistent infection of bovine virus diarrhoea virus in pigs: clinical, virological and immunological observations.
Terpstra C; Wensvoort G
Vet Q; 1997 Sep; 19(3):97-101. PubMed ID: 9323848
[TBL] [Abstract][Full Text] [Related]
56. A search for RNA insertions and NS3 gene duplication in the genome of cytopathic isolates of bovine viral diarrhea virus.
Quadros VL; Mayer SV; Vogel FS; Weiblen R; Brum MC; Arenhart S; Flores EF
Braz J Med Biol Res; 2006 Jul; 39(7):935-44. PubMed ID: 16862285
[TBL] [Abstract][Full Text] [Related]
57. Evidence for biotype-specific effects of bovine viral diarrhoea virus on biological responses in acutely infected calves.
Lambot M; Joris E; Douart A; Lyaku J; Letesson JJ; Pastoret PP
J Gen Virol; 1998 Jan; 79 ( Pt 1)():27-30. PubMed ID: 9460918
[TBL] [Abstract][Full Text] [Related]
58. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine.
Brownlie J; Clarke MC; Hooper LB; Bell GD
Vet Rec; 1995 Jul; 137(3):58-62. PubMed ID: 8533232
[TBL] [Abstract][Full Text] [Related]
59. A direct high-throughput in Cell-ELISA for measuring infectivity of cytopathic and non-cytopathic bovine viral diarrhoea virus strains applied to the assessment of antiviral activity.
Quintana ME; Barone L; Forlenza MB; Trotta MV; Turco C; Mansilla FC; Cardoso NP; Capozzo AV
J Virol Methods; 2018 Oct; 260():75-81. PubMed ID: 30031751
[TBL] [Abstract][Full Text] [Related]
60. Experimental production of fatal mucosal disease in cattle.
Brownlie J; Clarke MC; Howard CJ
Vet Rec; 1984 Jun; 114(22):535-6. PubMed ID: 6087539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]